Reazur Rasul

CIK 1967379 · EVP,Group Pres,Healthcare · last filed 2026-03-10

Reazur Rasul is an EVP,Group Pres,Healthcare who has filed 14 SEC Form 4 insider transactions across 1 company since 2023. The most recent filing shows the insider had shares withheld for taxes covering $224.2K of BAX on Mar 10, 2026. Current disclosed insider exposure totals $2.6M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$2.62M

Companies

1

Total Filings

14

Lifetime Open-Market Net

$0

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
BAX EVP,Group Pres,Healthcare 125,557 $20.86 $2.62M $0 14 2026-03-10

Recent Filings

14 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2026-03-10 BAX Tax (F) −12,674 -$224.2K EDGAR
2026-03-03 BAX Tax (F) −1,614 -$31.8K EDGAR
2026-02-11 BAX Mixed +13,181 -$125.4K EDGAR
2025-03-10 BAX Mixed +16,879 -$331.0K EDGAR
2025-03-05 BAX Tax (F) −1,987 -$69.3K EDGAR
2024-12-04 BAX Tax (F) −2,032 -$68.2K EDGAR
2024-03-08 BAX Grant (A) +83,353 $0 EDGAR
2024-03-06 BAX Tax (F) −522 -$22.2K EDGAR
2024-03-05 BAX Tax (F) −1,538 -$63.1K EDGAR
2024-02-14 BAX Mixed +468 -$10.0K EDGAR
Showing 110 of 14
Page 1 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.